HIKMA INTL PHARMS FDA Approval ANDA 076490

ANDA 076490

HIKMA INTL PHARMS

FDA Drug Application

Application #076490

Application Sponsors

ANDA 076490HIKMA INTL PHARMS

Marketing Status

Discontinued001

Application Products

001TABLET, EXTENDED RELEASE;ORAL450MG0LITHIUM CARBONATELITHIUM CARBONATE

FDA Submissions

ORIG1AP2003-06-17
MANUF (CMC); Manufacturing (CMC)SUPPL2AP2007-06-19
LABELING; LabelingSUPPL3AP2007-10-05
LABELING; LabelingSUPPL10AP2018-12-06STANDARD
LABELING; LabelingSUPPL11AP2018-12-20STANDARD
LABELING; LabelingSUPPL12AP2020-02-05STANDARD

Submissions Property Types

SUPPL2Null0
SUPPL10Null7
SUPPL11Null15
SUPPL12Null15

CDER Filings

HIKMA INTL PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 76490
            [companyName] => HIKMA INTL PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"LITHIUM CARBONATE","activeIngredients":"LITHIUM CARBONATE","strength":"450MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"LITHIUM CARBONATE","submission":"LITHIUM CARBONATE","actionType":"450MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.